arrow
T

Tracy L. Rose

University of North Carolina at Chapel Hill
H指数:22
被引数:2,527

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling

APOBEC3通过IL-1A/AP-1信号促进鳞状细胞分化

2025-12-140
OAAI
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer

免疫特征与对新辅助化疗免疫治疗肌肉浸润性膀胱癌的反应相关

2024-05-243
OAAI
Spatial Relationships in the Tumor Microenvironment Demonstrate Association with Pathologic Response to Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer
2024-03-018
OA
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression
2024-01-169
OAAI
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study

Durvalumab联合卡介苗 (BCG) 或体外放射治疗对BCG无反应的非肌肉浸润性膀胱癌患者的1期试验: Hoosier癌症研究网络GU16-243 ADAPT-bt研究

2023-06-0119
OA
Metastatic renal cell carcinoma to the pancreas and other sites -a multicenter retrospective study
2023-06-019
OAAI
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience (vol 125, pg 1251, 2021)
2022-03-112
OA
Entinostat induces antitumor immune responses through immune editing of tumor neoantigens

恩替诺特通过肿瘤新抗原的免疫编辑诱导抗肿瘤免疫应答

2021-08-1656
OA
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience

转移性尿路上皮癌中成纤维细胞生长因子受体3的改变和对免疫检查点抑制的反应: 真实世界的经验

2021-07-22109
OAAI